Displaying drugs 8151 - 8175 of 9261 in total
Ciglitazone
Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class.
Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to the market....
Experimental
Creatinine
Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.
Investigational
Intepirdine
Intepirdine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Enibomal
Experimental
4-phospho-L-threonic acid
Experimental
S-Methylcysteine
Experimental
Dinor-N(Omega)-Hydroxy-L-Arginine
Experimental
Latrunculin A
Latrunculin A is an actin binding macrolide purified from the red sea sponge Latrunculia magnifica. It is under investigation for the treatment of cancer. It disrupts actin polymerization, prevents mitotic spindle formation and thus cell replication.
Experimental
Des(carbamimidoyl) zanamivir
Experimental
Mevinolinic acid
Experimental
D-arginine
A D-α-amino acid that is the D-isomer of arginine (only the L-form is physiologically active).
Experimental
N(2)-(2-carboxyethyl)-L-arginine
Experimental
S-sulphocysteine
Experimental
KP-1461
KP-1461 is a potent, non-chain-terminating, mutagenic deoxyribonucleoside analogue. Designated a DNA covert nucleoside, the drug consists of a modified base that incorporates randomly into HIV and pairs with multiple bases.
Investigational
Lestaurtinib
Investigational
3-(INDOL-3-YL) LACTATE
Experimental
Displaying drugs 8151 - 8175 of 9261 in total